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Introduction
Despite advances in both prenatal diagnosis and neonatal
care, newborn infants with congenital diaphragmatic hernia
(CDH) continue to experience high mortality rates,1–8 which
are mainly attributed to pulmonary hypoplasia and persistent
pulmonary hypertension.1–10 Pulmonary hypoplasia and
pulmonary hypertension are a consequence of herniation of
the viscus into the chest during the critical stages of pulmonary
development.1,2,7,10
Pulmonary surfactant, which contains phospholipids and
a certain amount of specific proteins (surfactant
apolipoproteins, SPs), prevents alveolar collapse. The synthesis
of pulmonary surfactant is thus one of the most important
processes in the maturation of the fetal lung. These proteins have
recently been divided into four species: SP-A, -B, -C, and -D.
SP-A is the most abundant and its physicochemical proteins
have been well characterized. SP-A is also a useful marker for
assessing the functional maturation of lung tissue.10–13
We previously reported that, compared to the lungs of
gestational and postnatal age-matched control cases, lungs of
Address correspondence and reprint requests to Dr. Koushi Asabe, Division of Pediatric Surgery, Maternity and Perinatal
Care Center, Fukuoka University School of Medicine, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan.
E-mail: asabe@fukuoka-u.ac.jp • Date of acceptance: 23rd April, 2003
Immunohistochemical Distribution of Surfactant
Apoprotein-A in Congenital Diaphragmatic Hernia–II
CDH cases showed a significant reduction in SP-A expression
in alveolar type II cells.10 It has been reported that SP-A is
synthesized and released by alveolar type II cells and airway
epithelial cells.10,14–19 However, to the best of our knowledge,
there have been no immunohistochemical studies of the
expression and localization of SP-A in bronchiolar epithelial
cells associated with CDH. Therefore, this immunohisto-
chemical study aimed to estimate the functional maturity of
lungs in CDH cases using SP-A expression in the bronchiole as
measured with an antibody to SP-A, and to compare the
findings with pulmonary functional maturity in a gestational
and postnatal age-matched control group. It also aimed to
clarify the pathophysiological aspects of CDH.
Materials and methods
Lung specimens
Lungs obtained at autopsy from 18 infants, including nine
CDH infants and nine control cases of a comparable gestational
and postnatal age, were examined. Cases with a postmortem
delay of less than 24 hours were selected. Both lungs from all
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Morphometric analyses of the immunohistochemical expression of surfactant apoprotein A (SP-A) were carried
out on the bronchioles of human congenital diaphragmatic hernia (CDH) neonates and then compared with
those in a gestational and postnatal age-matched control group. There was no difference in SP-A expression
between lung specimens of the control group and unaffected lungs in the CDH group. However, compared with
both these lungs, the ipsilateral lungs of the CDH group showed a significant increase in SP-A expression, namely,
the number of SP-A-positive cells per bronchiole, the number of SP-A-positive cells per unit perimeter of
bronchiole, and the number of SP-A-positive cells per unit bronchiolar surface area. These results suggest that in
lungs of CDH cases, especially ipsilateral lungs, there is a possible delay in the functional maturation or
development of SP-A synthesis by the bronchiole, and this retardation may play a role in the postnatal respiratory
insufficiency observed in CDH patients. [Asian J Surg 2003;26(4):205–9]
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18 cases were used for light microscopy and immunohisto-
chemical examinations. The clinicopathological data have
been previously described in detail.10
Immunohistochemistry
The blocks of paraffin-embedded lung tissue were cut to give
4 µm sections which were then mounted onto slides precoated
with ovalbumin. Sections were immunohistochemically
examined using the avidin-biotin peroxidase complex
technique20 that used rabbit anti-immunoglobulin (Ig) G
against human SP-A with a molecular weight of 35 kDa
(a gift from K. Sueishi, Department of Pathology, Graduate
School of Medical Science, Kyushu University, Fukuoka,
Japan).11,17,21,22 Deparaffinized sections were washed three
times with 0.1 M phosphate-buffered saline (PBS), pH 7.4.
The following steps were carried out using a Histofine
SAB-PO® Kit (Nichirei Co., Tokyo, Japan). Briefly, after
preincubation with normal goat serum, each section was incu-
bated with rabbit anti-SP-A IgG at 5 µg/mL for 45 minutes at
room temperature and then washed with PBS. The sections
were then incubated with biotinylated goat anti-rabbit IgG for
45 minutes at room temperature. Endogenous peroxidase was
blocked using 0.3% w/v hydrogen peroxide in absolute metha-
nol for 30 minutes. Thereafter, sections were incubated with
streptavidin-biotinylated horseradish peroxidase complex for
30 minutes and washed with PBS. They were then incubated
with a peroxidase substrate solution containing 0.02% w/v
hydrogen peroxidase and 0.1% w/v diaminobenzidine
tetrahydrochloride in PBS, pH 7.4. After washing, the sections
were counterstained with hematoxylin.
Positive controls (adult lung specimens without any serious
pathological lesions) underwent simultaneous staining. Non-
immune rabbit serum was used instead of the primary anti-
SP-A IgG as a negative control.
Morphometric study
Lung/body weight ratio was determined. The radial alveolar
count (RAC) was measured on sections stained with
hematoxylin and eosin according to the method of Askenazi
and Perlman.23 Fifty sites were examined for each case.
A morphometric analysis was performed using the National
Institutes of Health Image 1.60 image processing software
(National Institutes of Health, Bethesda, MD, USA) according
to the modified morphometric analysis of Xu et al.18 The
length of the subepithelial basement membrane of the
bronchiole (bronchiole perimeter), the area enclosed by the
subepithelial basement membrane of the bronchiole
(bronchiolar surface area), and the number of SP-A-positive
cells within the respective bronchiole were used to calculate
the numbers of SP-A-positive cells per bronchiole, the number
of SP-A-positive cells per unit perimeter of bronchiole
(number/mm), and the number of SP-A-positive cells per
unit bronchiolar surface area (number/mm2). At least 50 sites
were examined for each case.
Statistical analysis
Results are expressed as the mean ± standard deviation.
Significant differences in immunohistochemical results
between the CDH and control groups were determined using
analysis of variance (ANOVA). All other parameters have been
previously described.10 A p value of less than 0.05 was con-
sidered statistically significant.
Results
There were no differences in the age at death, gestational age,
blood gas data or duration of ventilation therapy between
CDH and control cases (Table).10 Although a slight difference
in the respiratory support type was noted between the groups,
the conditions of respiratory support were fundamentally the
same in both groups. The lung/body weight ratio in the CDH
group (0.010 ± 0.0005) was less than that in the control group
(0.021 ± 0.013; p < 0.01) (Table).
The RAC in the CDH group (2.10 ± 0.50) was consistently
and significantly less than that in the control group (3.48 ±
0.39; p < 0.01). In addition, in the CDH group, the RAC in the
lung on the affected side (1.71 ± 0.34) was consistently and
significantly less than that in the lung on the unaffected side
(2.50 ± 0.26) (p < 0.01). This showed that the lungs on the
affected side in CDH cases were hypoplastic, while those on
the unaffected side were only somewhat hypoplastic.
The bronchiolar epithelium in all lungs of both CDH and
control cases contained SP-A-positive cells. Light microscopy
showed that SP-A-positive cells in the airway mucosa were
non-ciliated cuboidal cells (Figure 1).
There was no difference in SP-A-positive cell numbers
between the lungs of the control group and the unaffected
lungs of the CDH group (number of SP-A-positive cells per
bronchiole: 2.87 ± 4.61 vs 2.92 ± 4.74; number of SP-A-positive
cells per unit perimeter of bronchiole: 2.85 ± 1.96/mm vs 3.23 ±
1.62/mm; number of SP-A-positive cells per unit bronchiolar
surface area: 40.44 ± 17.54/mm2 vs 42.25 ± 15.86/mm2).
However, compared with both the lungs in the control group
and the lungs on the unaffected side in the CDH group,
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Discussion
In this study, SP-A-positive cells on the epithelium of the
bronchiole in human hypoplastic lungs with CDH were
quantified using morphometric analyses and immuno-
histochemical methods. Compared with lungs in gestational
affected lungs in the CDH group showed a significant increase
in SP-A expression (number of SP-A-positive cells per
bronchiole: 4.22 ± 6.56, p < 0.05; number of SP-A-positive cells
per unit perimeter of bronchiole: 4.46 ± 2.38/mm, p < 0.05;
number of SP-A-positive cells per unit bronchiolar surface
area: 48.34 ± 17.30/mm2, p < 0.05) (Figures 2, 3 and 4).
Table. Clinical data
CDH (n = 9) Control (n = 9)
Gestational age (wk) 37.6 ± 3.9 37.9 ± 4.4
Birth weight (g) 2,584 ± 840 2,732 ± 832
Lung/body weight ratio* 0.010 ± 0.005 0.021 ± 0.013
Age at death (d) 3.11 ± 2.28 4.67 ± 5.27
Type of ventilation
IMV 7 9
HFO 1
IMV + HFO 1
Duration of ventilation (hr) 64.1 ± 54.0 59.8 ± 73.3
Blood gas data
pH 7.07 ± 0.18 7.02 ± 0.29
pO2 (mmHg) 83.3 ± 91.5 69.3 ± 46.7
pCO2 (mmHg) 75.2 ± 38.8 51.1 ± 16.8
BE (mmol/L) –12.2 ± 8.9 –16.6 ± 11.4
AaDO2 (mmHg) 554.6 ± 85.6 592.6 ± 49.5
CDH = congenital diaphragmatic hernia; IMV = intermittent mandatory ventilation; HFO = high frequency oscillation; pO2 = partial
pressure of oxygen; pCO2 = partial pressure of carbon dioxide; BE = base excess; AaDO2 = alveolar arterial difference in oxygen content.
*p < 0.01.
Figure 1. Surfactant apoprotein A-positive cells (arrows) in the non-
cartilaginous airway in the lung on the affected side (left) in a
control case at 26 gestational weeks (original magnification x 80).
Figure 2. The number of surfactant apoprotein (SP)-A-positive cells
per bronchiole in congenital diaphragmatic hernia (CDH)-affected
side, CDH-unaffected side and control lungs were 4.22 ± 6.56, 2.92 ±
4.74 and 2.87 ± 4.61, respectively. *p < 0.05.
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and postnatal age-matched controls, CDH lungs, especially on
the affected side, showed a significant increase in SP-A
expression, i.e. in the numbers of SP-A-positive cells per
bronchiole, SP-A-positive cells per unit perimeter of bronchiole,
and SP-A-positive cells per unit bronchiolar surface area. These
results suggest that there may be a delay in the functional
maturation or development of SP-A synthesis in the bronchioles
of lungs in patients with CDH, and this retardation of func-
tional maturation at the bronchiolar level may also play a role
in postnatal respiratory insufficiency in CDH patients.
Recently, Xu et al described the morphometric analysis of
immunohistochemical expression of SP-A using rabbit
anti-IgG against human SP-A (the same antibody as used in
this report).17,18 They reported that the earliest SP-A expres-
sion was detected in the epithelial cells of the main bronchus
at 15 gestational weeks. The number of SP-A-positive cells in
the bronchial epithelium gradually increased until 23 gesta-
tional weeks and gradually decreased thereafter. SP-A-positive
bronchiolar cells demonstrated a different pattern of expression
to that of SP-A cells in the bronchi. The number of SP-A-
positive bronchiolar cells decreased from 18 gestational weeks
as gestation progressed, and these cells were mainly localized
in the respiratory bronchioles. SP-A expression began
prominently in the proximal portion of the airway (main
bronchus) and then spread through the bronchioles into the
distal portion of the airway (alveoli).
All cases examined in this study were older than 26
gestational weeks. We thus expected SP-A expression to be
mainly detected in the respiratory bronchioles, and assumed
that SP-A-positive cells in the bronchioles would be more
common in the CDH group than in the control group. This
immunohistochemical study was performed to quantitatively
assess the distribution of SP-A-positive cells in the bronchioles.
Hypoplastic lung associated with CDH is related to deficient
airway generation.24,25 Beals et al found that lungs on the
unaffected side had 63% normal airway generation, whereas
lungs on the affected side had only 44% of the normal number
of airways.25 Wigglesworth et al reported that the hypoplastic
lung on the affected side in CDH has an immature structure
with a low phospholipid concentration, whereas the lung on
the unaffected side is both structurally and biochemically
more mature.26 We also previously reported that, compared
with gestational and postnatal age-matched controls, lungs of
CDH cases, especially on the affected side, show a significant
reduction in SP-A expression in alveolar type II cells. We
speculated that these results suggest that in the lungs of CDH
cases, there may be a delay in SP-A synthesis by alveolar type II
cells.10 This study found that CDH lungs, especially on the
affected side, show a significant increase in SP-A expression in
the bronchioles. Whereas the number of SP-A-positive cells in
alveolar type II cells increased with advancing gestation, the
number of SP-A-positive bronchiolar cells decreased as
gestation progressed.17,18 Therefore, all these findings suggest
that there may be a delay in the functional maturation or the
development of SP-A synthesis by the bronchioles in CDH lungs.
The exact mechanism of the functional maturation or the
development of such hypoplastic CDH lungs remains to be
elucidated, especially in the airways. Further studies using
other mediators are now being performed in our department.
Figure 3. The number of surfactant apoprotein (SP)-A-positive cells
per unit perimeter of bronchiole in congenital diaphragmatic hernia
(CDH)-affected side, CDH-unaffected side and control lungs were
4.46 ± 2.38/mm, 3.23 ± 1.62/mm and 2.85 ± 1.96/mm, respectively.
*p < 0.05.
Figure 4. The number of surfactant apoprotein (SP)-A-positive cells
per unit bronchiolar surface area in congenital diaphragmatic
hernia (CDH)-affected side, CDH-unaffected side and control
lungs were 48.34 ± 17.30/mm2, 42.25 ± 15.86/mm2 and 40.44 ±
17.54/mm2, respectively. *p < 0.05.
12
10
8
6
4
2
0N
um
be
r 
of
 S
P-
A
-p
os
it
iv
e 
ce
lls
 p
er
un
it
 p
er
im
et
er
 (
m
m
) 
of
 b
ro
nc
hi
ol
e
CDH- CDH- Control
affected unaffected
*
*
120
100
80
60
40
20
0
N
um
be
r 
of
 S
P-
A
-p
os
it
iv
e 
ce
lls
 p
er
 u
ni
t
br
on
ch
io
la
r 
su
rf
ac
e 
ar
ea
 (
m
m
2 )
CDH- CDH- Control
affected unaffected
*
*
ASIAN JOURNAL OF SURGERY  VOL 26 • NO 4 • OCTOBER 2003 209
070/2001
n  IMMUNOHISTOCHEMICAL DISTRIBUTION OF SP-A IN CDH n
Acknowledgement
The authors would like to thank Brian T. Quinn for his
comments on the manuscript.
References
1. Hashimoto EG, Pringle KC, Soper RT, Brown CK. The creation and
repair of diaphragmatic hernia in fetal lambs: morphology of the
type II alveolar cell. J Pediatr Surg 1985;20:354–6.
2. Glick PL, Stannard VA, Leach CL, et al. Pathophysiology of congenital
diaphragmatic hernia II: the fetal lamb CDH model is surfactant
deficient. J Pediatr Surg 1992;27:382–8.
3. Glick PL, Leach CL, Besner GE, et al. Pathophysiology of congenital
diaphragmatic hernia III: exogenous surfactant therapy for the
high-risk neonate with CDH. J Pediatric Surg 1992;27:866–9.
4. Suen H, Catlin EA, Ryan DP, et al. Biochemical immaturity of lungs
in congenital diaphragmatic hernia. J Pediatr Surg 1993;28:471–7.
5. Sullivan KM, Hawgood S, Flake AW, et al. Amniotic fluid
phospholipid analysis in the fetus with congenital diaphragmatic
hernia. J Pediatr Surg 1994;29:1020–4.
6. Utsuki T, Honna T, Sugiyama M, et al. Pulmonary surfactant in
hypoplastic lung of fetal rat with congenital diaphragmatic hernia.
Jpn J Pediatr Surg 1994;26:1063–9.
7. Wilcox DT, Glick PL, Karamanoukian HL, et al. Pathophysiology of
congenital diaphragmatic hernia XII: amniotic fluid lecithin/
sphingomyelin ratio and phosphatidylglycerol concentrations do
not predict surfactant status in congenital diaphragmatic hernia.
J Pediatr Surg 1995;30:410–2.
8. Hassett MJ, Glick PL, Karamanoukian HL, et al. Pathophysiology of
congenital diaphragmatic hernia XVI: elevated pulmonary collagen
in the lamb model of congenital diaphragmatic hernia. J Pediatr
Surg 1995;30:1191–4.
9. Shimizu H, Ogawa Y. Pulmonary surfactant in congenital
diaphragmatic hernia. Jpn J Pediatr Surg 1995;27:1343–7.
10. Asabe K, Tsuji K, Handa N, et al. Immunohistochemical distribution
of surfactant apoprotein-A in congenital diaphragmatic hernia.
J Pediatr Surg 1997;32:667–72.
11. Toki N, Sueishi K, Minamitani M, et al. Immunohistochemical
distribution of surfactant apoproteins in hypoplastic lungs of
nonimmunologic hydrops fetalis. Hum Pathol 1995;26:1252–9.
12. Asabe K, Toki N, Hashimoto S, et al. An immunohistochemical
study of the expression of surfactant apoprotein in the hypoplastic
lung of rabbit fetuses induced by oligohydramnios. Am J Pathol
1994;145:631–9.
13. Asabe K, Hashimoto S, Suita S, Sueishi K. Maternal dexamethasone
treatment enhances the expression of surfactant apoprotein-A in
the hypoplastic lung of rabbit fetuses induced by oligohydramnios.
J Pediatr Surg 1996;31:1369–75.
14. Hawgood S, Clements JA. Pulmonary surfactant and its apoproteins.
J Clin Invest 1990;86:1–6.
15. Walker SR, Williams MC, Benson B. Immunocytochemical
localization of the major surfactant apoproteins in type II cells,
Clara cells, and alveolar macrophages of rat lung. J Histochem
Cytochem 1986;34:1137–48.
16. Endo H, Oka T. An immunohistochemical study of bronchial cells
producing surfactant protein A in the developing human fetal lung.
Early Hum Dev 1991;25:149–56.
17. Xu P, Hashimoto S, Asabe K, Sueishi K. Expression of Clara cell 10-
KDa protein (CC10), surfactant apoprotein-A and B (SP-A and B) in
the developing airways of the human lungs. J Jpn Med Soc Biol
Interface 1994;25:153–5.
18. Xu P, Hashimoto S, Asabe K, et al. Morphometrical analysis of the
immunohistochemical expression of Clara cell 10 kDa protein (CC10)
and surfactant apoprotein A and B in the developing bronchi and
bronchioles of human fetuses and neonates. Virchows Archiv 1998;
432:17–25.
19. Yoneyama K. Immunohistochemical localization of pulmonary
surfactants in fetal rabbit lung. Nippon Sanka Fujinka Gakkai Zasshi
1988;40:1740–6.
20. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex
(ABC) in immunoperoxidase techniques: a comparison between
ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem
1981;29:577–80.
21. Dairaku M, Sueishi K, Tanaka K, Horie A. Immunohistological
analysis of surfactant-apoprotein in the bronchiolo-alveolar car-
cinoma. Virchows Arch A Pathol Anat Histopathol 1983;400:223–34.
22. Nagata N, Dairaku M, Ishida T, et al. Sclerosing hemangioma of the
lung: immunohistochemical characterization of its origin as related
to surfactant apoprotein. Cancer 1985;55:116–23.
23. Askenazi SS, Perlman M. Pulmonary hypoplasia: lung weight and
radial alveolar count as criteria of diagnosis. Arch Dis Child 1979;54:
614–8.
24. Nakamura Y, Yamamoto I, Fukuda S, Hashimoto T. Pulmonary
acinar development in diaphragmatic hernia. Arch Pathol Lab Med
1991;115:372–6.
25. Beals DA, Schloo BL, Vacanti JP, et al. Pulmonary growth and
remodeling in infants with high-risk congenital diaphragmatic
hernia. J Pediatr Surg 1992;27:997–1002.
26. Wigglesworth JS, Desai R, Guerrini P. Fetal lung hypoplasia:
biochemical and structural variations and their possible significance.
Arch Dis Child 1981;56:606–15.
